IO Biotech Inc reported a net loss of $95.5M in fiscal year 2024. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 5 fiscal years, from 2020 to 2024, and the quarters IO Biotech Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
IOBTQ Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
IOBTQ Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More IO Biotech Inc financials
Frequently Asked Questions
IO Biotech Inc reported a net loss of $95.5M in fiscal year 2024.
IO Biotech Inc (IOBTQ) reported a $86.1M net loss in fiscal year 2023 and a $95.5M net loss in fiscal year 2024. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Across the 5 fiscal years this page covers, IO Biotech Inc (IOBTQ) net income went from -$12.0M in fiscal year 2020 to -$95.5M in fiscal year 2024.
IO Biotech Inc (IOBTQ) reported -$8.4M in net income in Q3 2025. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what IO Biotech Inc (IOBTQ) reported on that line in every period on record.